<DOC>
	<DOCNO>NCT01706185</DOCNO>
	<brief_summary>This study aim analyze incidence expression MAGE-A3 , MAGE-C2 , NY-ESO-1 , LAGE-1 , WT1 PRAME tumor antigens cancer tissue patient pathologically demonstrate bladder cancer .</brief_summary>
	<brief_title>Incidence Expression Tumor Antigens Cancer Tissue From Patients With Pathologically Demonstrated Bladder Cancer</brief_title>
	<detailed_description>There procedure ( ) treatment ( ) carry patient . All data sample take already store investigation site . Clinical data collect include patient demographic ( age , gender ) , Tumor , Node , Metastasis ( stag system ) [ TNM stage ] , histopathologic description . Strict anonymity patient data maintain . This retrospective study base upon analysis archive formalin-fixed paraffin-embedded tissue sample patient-related data already available investigational site .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>For inclusion tissue sample , follow criterion must meet : The patient pathologically proven bladder cancer ( stage ) . All data require available patient 's record . There restriction regard operative technique ( cystectomy cystoscopy ) . Many patient may longer alive , long contact investigation site . Thus , patient require give informed consent inclusion study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Patients</keyword>
	<keyword>Tumor antigen</keyword>
	<keyword>Bladder cancer</keyword>
</DOC>